Vivos Therapeutics, Inc. announced the execution of a strategic marketing and distribution alliance with an operator of multiple sleep testing and treatment centers in Colorado. This alliance, which Vivos hopes will be the first of a series of similar alliances across the country, marks an important pivot in Vivos' marketing and distribution model for its cutting edge OSA appliances. Under the new alliance, Vivos and the sleep center operator have agreed to collaborate to offer OSA patients a full spectrum of evidence-based treatments such as continuous positive airway pressure (CPAP) machines, and Vivos' advanced, proprietary and FDA-cleared CARE oral medical devices, oral appliances and additional adjunctive therapies and methods offered by Vivos.

The program will commence in two existing sleep treatment centers in Colorado, with operations expected to begin in July 2024. Vivos' sleep center collaborator is presently rebranding its name in light of the new alliance, and Vivos expects to be able to share further details in the near future. The new marketing and distribution strategic alliance is based on a revenue-sharing model between Vivos and the sleep center operator.